Impact of Folic Acid Supplements on Autism Diagnosis
Study Overview
Researchers have explored the relationship between folic acid supplements taken before and during pregnancy and the subsequent diagnosis of autism in their children. Autism spectrum disorder (ASD) encompasses a range of developmental disorders characterized by various symptoms, including social challenges, sensory sensitivities, limited interests, and communication difficulties. While the exact cause of autism remains unclear, scientists are actively seeking modifiable risk factors that could potentially reduce its incidence.
The Role of Maternal Nutrition
Maternal nutrition is a significant modifiable risk factor for numerous health conditions. Folic acid and multivitamin supplements are generally recommended for all pregnant women. Although many studies have examined the influence of maternal nutrition on autism development, findings have often been inconsistent. Folic acid deficiency has been linked to cognitive development issues in fetuses, prompting researchers to evaluate its potential connection to autism risk.
Research Methodology
In Israel, a study followed 43,300 children from birth to 10 years, tracking maternal supplement use and any autism diagnoses. Researchers utilized pharmacy dispensing records to determine vitamin prescriptions before (540-271 days prior to childbirth) and during pregnancy (270 days up to childbirth). Other factors, such as family psychiatric history, socioeconomic status, and gender, were also considered. By the conclusion of the study, 572 children had received an autism diagnosis, which was verified using the International Classification of Diseases. The findings were published in JAMA Psychiatry.
Key Findings
The study revealed a significant correlation between maternal folic acid supplementation and a reduced likelihood of autism diagnosis in offspring. Notably, exposure to folic acid or multivitamins before and during pregnancy was associated with a statistically significant lower risk of autism compared to no supplementation. Although the correlation was slightly weaker for female children, this may be attributed to the smaller sample size of females diagnosed with autism.
Importantly, the research indicated no significant reduction in autism diagnoses among children of mothers with psychiatric conditions, despite their use of folic acid supplements. This outcome may be linked to lower adherence to supplement regimens or higher rates of vitamin deficiency among those with mental health issues. Further research is needed to better understand these associations.
Conclusions and Implications
Comprehensive statistical analyses highlighted that the benefits of folic acid and multivitamin supplementation were evident regardless of pre-existing vitamin deficiencies. This suggests that autism development is not solely a result of vitamin deficiency, but may be influenced by supplementation in other ways.
This study supports earlier research indicating that maternal folic acid supplementation could help mitigate autism risk in children. It uniquely demonstrates that this protective association holds true even during the extensive pre-pregnancy period. These findings carry significant health implications for women of childbearing age, emphasizing the potential benefits of folic acid supplementation before pregnancy for the health of future children.
Reference
Levine SZ, Kodesh A, Viktorin A, et al. Association of Maternal Use of Folic Acid and Multivitamin Supplements in the Periods Before and During Pregnancy With the Risk of Autism Spectrum Disorder in Offspring. JAMA Psychiatry. 2018.